Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study
Dapagliflozin has been demonstrated to improve glycemic control, blood pressure, and body weight in type 2 diabetes mellitus (T2D); indeed, it can also reduce the risk of progression to renal failure, of hospitalization for heart failure and of cardiovascular death. We aim to investigate the acute e...
Saved in:
Similar Items
-
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
by: Maria Elena Lunati, et al.
Published: (2024) -
eATP and autoimmune diabetes
by: Cristian Loretelli, et al.
Published: (2023) -
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease
by: Adriana Petrazzuolo, et al.
Published: (2023) -
Antinuclear antibodies in COVID 19
by: Paolo Muratori, et al.
Published: (2021) -
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study
by: Maria Elena Lunati, et al.
Published: (2022)